Total Payments
$54,823
2024 Payments
$4,535
Companies
47
Transactions
1,155
Medicare Patients
1,226
Medicare Billing
$212,680
Payment Breakdown by Category
Food & Beverage$33,832 (61.7%)
Consulting$8,556 (15.6%)
Other$5,469 (10.0%)
Research$3,568 (6.5%)
Travel$2,803 (5.1%)
Education$595.49 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $33,832 | 1,112 | 61.7% |
| Consulting Fee | $8,556 | 6 | 15.6% |
| Honoraria | $5,469 | 4 | 10.0% |
| Unspecified | $3,568 | 1 | 6.5% |
| Travel and Lodging | $2,803 | 11 | 5.1% |
| Education | $595.49 | 21 | 1.1% |
Payments by Type
General
$51,255
1,154 transactions
Research
$3,568
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $10,458 | 50 | $0 (2024) |
| Octapharma USA, Inc. | $7,255 | 55 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $4,464 | 13 | $0 (2024) |
| CSL Behring | $4,195 | 159 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,054 | 77 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,467 | 90 | $0 (2024) |
| GENZYME CORPORATION | $1,777 | 62 | $0 (2024) |
| Grifols USA, LLC | $1,757 | 77 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,627 | 68 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,613 | 48 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,535 | 149 | CSL Behring ($695.14) |
| 2023 | $10,542 | 188 | Genentech USA, Inc. ($4,661) |
| 2022 | $10,138 | 195 | Regeneron Pharmaceuticals, Inc. ($3,829) |
| 2021 | $4,781 | 163 | Octapharma USA, Inc. ($926.37) |
| 2020 | $2,433 | 98 | AstraZeneca Pharmaceuticals LP ($300.24) |
| 2019 | $7,828 | 116 | Genentech USA, Inc. ($4,133) |
| 2018 | $9,705 | 129 | Octapharma USA, Inc. ($5,211) |
| 2017 | $4,862 | 117 | AstraZeneca Pharmaceuticals LP ($818.36) |
All Payment Transactions
1,155 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: Immunology | ||||||
| 12/19/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $33.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Immunology and Neurology | ||||||
| 12/13/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $66.06 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.80 | General |
| Category: Immunology | ||||||
| 12/04/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $35.50 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Immunology and Neurology | ||||||
| 11/14/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $5.59 | General |
| Category: Immunology | ||||||
| 11/13/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $68.86 | General |
| 11/11/2024 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $33.67 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: Immunology and Neurology | ||||||
| 10/29/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $30.92 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $21.42 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/25/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $134.75 | General |
| Category: Inflammation & Immunology | ||||||
| 10/23/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $36.40 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Kedrion Biopharma, Inc. | Albuked (Biological), KOATE, GAMMAKED | Food and Beverage | Cash or cash equivalent | $83.40 | General |
| Category: Critical Care | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) | Regeneron Pharmaceuticals, Inc. | $3,568 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 321 | 3,166 | $82,731 | $53,961 |
| 2022 | 8 | 316 | 4,602 | $87,252 | $55,155 |
| 2021 | 9 | 291 | 2,903 | $82,506 | $51,522 |
| 2020 | 8 | 298 | 3,542 | $83,625 | $52,043 |
Total Patients
1,226
Total Services
14,213
Medicare Billing
$212,680
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 80 | 156 | $27,300 | $20,342 | 74.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 58 | 58 | $14,500 | $10,129 | 69.9% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 28 | 2,523 | $17,661 | $9,139 | 51.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 73 | $8,890 | $6,790 | 76.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 39 | $3,730 | $2,834 | 76.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 46 | 210 | $6,360 | $2,581 | 40.6% |
| 95018 | Test for allergy using combination of methods with drug or biological | Office | 2023 | 18 | 71 | $2,130 | $1,295 | 60.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 18 | 36 | $2,160 | $850.85 | 39.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 63 | 118 | $20,670 | $14,977 | 72.5% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 36 | 3,966 | $27,762 | $14,675 | 52.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 59 | 59 | $14,750 | $10,572 | 71.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 83 | $9,960 | $7,509 | 75.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 39 | 222 | $6,660 | $2,725 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 32 | $3,040 | $2,243 | 73.8% |
| 95018 | Test for allergy using combination of methods with drug or biological | Office | 2022 | 26 | 97 | $2,910 | $1,842 | 63.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 15 | 25 | $1,500 | $613.75 | 40.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 59 | 142 | $24,850 | $18,807 | 75.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 114 | $13,680 | $9,662 | 70.6% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 24 | 2,103 | $14,721 | $7,958 | 54.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 37 | 37 | $9,250 | $6,140 | 66.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 36 | $3,420 | $2,584 | 75.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 35 | 147 | $4,410 | $1,798 | 40.8% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 11 | 197 | $6,895 | $1,772 | 25.7% |
| 95018 | Allergy testing with drugs or biologicals into or within the skin, immediate type reaction, including test interpretation and report | Office | 2021 | 22 | 78 | $2,340 | $1,538 | 65.7% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 18 | 49 | $2,940 | $1,264 | 43.0% |
About Dr. Stuart Epstein, MD
Dr. Stuart Epstein, MD is a Allergy healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265456610.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Epstein, MD has received a total of $54,823 in payments from pharmaceutical and medical device companies, with $4,535 received in 2024. These payments were reported across 1,155 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($33,832).
As a Medicare-enrolled provider, Epstein has provided services to 1,226 Medicare beneficiaries, totaling 14,213 services with total Medicare billing of $212,680. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy
- Location Beverly Hills, CA
- Active Since 07/27/2006
- Last Updated 07/08/2007
- Taxonomy Code 207KA0200X
- Entity Type Individual
- NPI Number 1265456610
Products in Payments
- Xolair (Biological) $11,202
- DUPIXENT (Biological) $6,454
- CUTAQUIQ (Biological) $5,150
- Hizentra (Biological) $3,288
- CUTAQUIG (Biological) $2,121
- CUVITRU (Biological) $1,885
- Xembify (Biological) $1,699
- Gammaplex (Drug) $1,509
- TEZSPIRE (Biological) $1,258
- DUPIXENT DUPILUMAB INJECTION (Biological) $935.24
- XOLAIR (Biological) $881.62
- NUCALA (Biological) $873.68
- EUCRISA (Drug) $680.31
- FASENRA (Drug) $654.17
- Odactra (Drug) $592.35
- Gammaplex 10% (Biological) $490.25
- TRELEGY ELLIPTA (Drug) $432.03
- AUVI-Q (Drug) $417.19
- RINVOQ (Biological) $410.97
- CIBINQO (Drug) $381.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.